Attached files
| file | filename |
|---|---|
| EX-99.2 - PRESS RELEASE - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | f8k062917ex99ii_bisoncapital.htm |
| 8-K - CURRENT REPORT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | f8k062917_bisoncapitalacq.htm |
Exhibit 99.1
BISON CAPITAL ACQUISITION CORP.
BALANCE SHEET
As of June 23, 2017
| June 23, | Pro Forma | Pro Forma | ||||||||||
| 2017 | Adjustments | Totals | ||||||||||
| (unaudited) | (unaudited) | |||||||||||
| ASSETS | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | $ | 941,372 | $ | — | $ | 941,372 | ||||||
| Prepaid expenses and other current assets | 24,500 | — | 24,500 | |||||||||
| Total Current Assets | 965,872 | — | 965,872 | |||||||||
| Cash held in Trust Account | 53,812,500 | 8,071,875 | 61,884,375 | |||||||||
| Total Assets | $ | 54,778,372 | $ | 8,071,875 | $ | 62,850,247 | ||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||
| Current liabilities | ||||||||||||
| Accounts payable and accrued expenses | $ | 10,300 | $ | — | $ | 10,300 | ||||||
| Advances from related party | 71,804 | — | 71,804 | |||||||||
| Promissory note – related party | 300,000 | — | 300,000 | |||||||||
| Total Liabilities | 382,104 | — | 382,104 | |||||||||
| Commitments and Contingencies | ||||||||||||
| Ordinary shares subject to possible redemption, 4,819,148 and 5,606,648 shares at redemption value | 49,396,267 | 8,071,875 | 57,468,142 | |||||||||
| Shareholders' Equity: | ||||||||||||
| Preferred shares, no par value; unlimited shares authorized; none issued and outstanding | — | — | — | |||||||||
| Ordinary shares, no par value; unlimited shares authorized; 2,328,977 and 2,372,289 shares issued and outstanding (excluding 4,819,148 and 5,606,648 shares subject to possible redemption) | 5,002,394 | — | 5,002,394 | |||||||||
| Accumulated deficit | (2,393 | ) | — | (2,393 | ) | |||||||
| Total Shareholders' Equity | 5,000,001 | — | 5,000,001 | |||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 54,778,372 | $ | 8,071,875 | $ | 62,850,247 | ||||||